chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initially, some dizziness, racing heart and shortness of breath within half an hour of shot. We thought it could be because of my alcohol sensitivity, which causes similar feelings when inhaled. Nurses said I could try getting fresh air. I stood outside for 15 minutes and started to feel better, except for the racing heart beat.  I went home.  A few hours later, the racing heart beat came back and was worse. I had mild chest pain, an itching arm and was sweating. I called a help line and was told that can happen sometimes and that it was okay to take Tylenol now, so I did.   The next day my heart was racing worse. I used a blood pressure cuff and checked my pulse rate. My BP was 181/90, which is high for me, especially on the linsopril. My pulse rate was 101 BPM. I also developed a fever and a painful and itchy rash on my arm. When I called the advice line they said that was still within non-emergency range. It went on like this for two weeks.   When I saw a doctor for something else, I mentioned all of it and they said I may be allergic to the shot. I was given prednisone for symptoms related to Lupus and my swollen arm. I was told I could get the second shot a f little later than originally planned.  However, even with prednisone and a pulse rate back down to 88 (high for me), I continue to have chest pains off and on. The swollen arm with a weird rash lasted for 5 weeks. I have to have a scan with contrast dye to monitor my brain tumor and insurance won?t approve them doing both at once, so still trying to schedule a look at my heart.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Prior to vaccination, it was unknown if patient diagnosed with COVID-19. It was unknown if patient receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown since the vaccination, has the patient been tested for COVID-19. The following information was reported: PARALYSIS (medically significant), outcome "unknown", described as "Paralyzed"; BLINDNESS (medically significant), outcome "unknown", described as "Lost vision". Clinical course reported: paralyzed, had to get a cochlear transplant, lost vision. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
11/01/22 presents to ED for "shortness of breath". PMHx of "epilepsy, dementia, dysphagia s/p PEG, expressive aphasia, DM 2 and hx of MRSA"
Breakthrough case admission after 4 vaccines Moderna 4/7/21 lot# 017B21A;  Moderna 9/16/21 lot# 053C21A;  Moderna 11/10/21 lot# 062E21A;  Moderna 7/25/22 lot# 006M21A
Joint pain all over my body.  Chills.  Slight headache, sore at injection site.  No problems date of injection, next morning, couldn't hardly move from the joint pain.  Lasted until about 6:00pm that evening.  Chills lasted all day until about 9:00pm.  Headache lasted all day until 9:00pm.  Arm injection site is still sore today.
Pain, redness and swelling at injection site. Temp of > 102. Papules on eyes and face with itching.
The pt developed ADEM (Acute disseminating encephalomyelitis), 2-3 weeks, after the vaccine. Doc 210871 reports residual neurological symptoms.
headache; muscle aches; sore achy muscles; fatigue; This is a spontaneous report from a contactable consumer. A 60-years-old male patient received BNT162B2(COMIRNATY, solution for injection, Batch/Lot number: EN6203), via an unspecified route of administration, administered in left arm on 04Mar2021 13:00 as 1ST DOSE, SINGLE for covid-19 immunisation.  Medical history included ongoing hypertension, ongoing pancreatitis, asthma from an unknown date and unknown if ongoing, overweight from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing. Concomitant medication(s) included hydralazine (HYDRALAZINE) taken for hypertension from an unspecified start date and ongoing; omeprazole (OMEPRAZOLE) taken for gastrooesophageal reflux disease from an unspecified start date and ongoing; insulin human injection, isophane (HUMULIN N) taken for diabetes mellitus from an unspecified start date and ongoing; insulin human (HUMULIN R) taken for diabetes mellitus from an unspecified start date and ongoing.  The patient previously took first dose of bnt162b2 for covid-19 immunisation, keflex [cefalexin monohydrate] and experienced drug hypersensitivity.  The patient experienced headache, muscle aches, sore achy muscles on 05Mar2021 04:00. Outcome of headache, muscle aches, sore achy muscles was unknown.  No follow up attempts are possible. No further information is expected.
Extreme body and joint pain three days after vaccine. Throbbing in legs, aching in arms, hip and shoulder pain. Doctor prescribed pain medication and muscle relaxer to try to help. I then had a leg ultrasound, hip MRI and was put on a steroid pack for inflammatory response. My psoriasis which was dormant flared and I have had to see the dermatologist who will be ordering blue light therapy to control the inflammation. Currently on anti-inflammatory medication to help with the pain however I haven't been able to workout or be as physically active as I was prior to the second dose vaccine.
1st shot.  Approximately 12 hours after vaccine, fever started.  Aspirin taken.  At 18 hours, knees, ankles, hips sore and achy.  By 36 hours, residual tiredness.
The medical assistant gave DTAP/IPV to a 3 year old, it is licensed for use with 4-6 year olds. I discovered this when the patient returned for the next dose. The patient had no adverse reactions, I wanted to submit the vaccine administration error.
Pinched Nerve entire Left Arm (After Second Vaccine); Entire left arm was in Pain; Headache; Rash left side of back and Shoulder-blade; Bad chills; Fever; Itching left side of back and Shoulder-blade; Throat Hurt; Dizziness; Felt weak; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced PRURITUS (Itching left side of back and Shoulder-blade), OROPHARYNGEAL PAIN (Throat Hurt), DIZZINESS (Dizziness), ASTHENIA (Felt weak), RASH (Rash left side of back and Shoulder-blade), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache). On 30-Apr-2021, the patient experienced NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain). On 29-Apr-2021, OROPHARYNGEAL PAIN (Throat Hurt), CHILLS (Bad chills), PYREXIA (Fever) and HEADACHE (Headache) had resolved. On 03-May-2021, PRURITUS (Itching left side of back and Shoulder-blade), DIZZINESS (Dizziness), ASTHENIA (Felt weak) and RASH (Rash left side of back and Shoulder-blade) had resolved. On 06-May-2021, NEURALGIA (Pinched Nerve entire Left Arm (After Second Vaccine)) and MYALGIA (Entire left arm was in Pain) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101F.         Patient's rash was the size of a baseball. Patient's family physician told her that the arm pain might be from a pinched nerve.  Action taken with mRNA-1273 in response to the event was not applicable  No relevant concomitant medications were reported.  No treatment information was provided.       Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Followup received on 04-Jun-2021; Added date for dose 1. Added new events Pruritis, Oropharyngeal pain, Dizziness, Asthenia, Pyrexia, neuralgia , Myalgia and Headache. Updated product information and date for dose 2. Updated start and stop dates of events Chills and Rash. Updated product-event details.
Patient got DTaP and Varicella in right thigh on 5/17, and that evening he had a large hard red area on the right thigh, was complaining that it was very itchy. Mom applied a warm compress and some ibuprofen. He continued to occasionally C/O itching at the right thigh, but was ok for the next few days on 05/21/12 he suddenly developed a lot of hives, was seen at local facility and prescribed Pepcid, prednisolone and Benadryl. Rash was somewhat better when he was seen in our office on 05/22/12 although he continueed to break out in hives sporadically. He did not have any eye, lip or ear swelling, no wheezing or vomiting at any point. Patient has not had an allergic reaction to anything before no new foods or other exposures and no recent sx's illness.
Received yellow cap 0.2mL/10ug instead of 0.25ml/25 ug dose- Lower than authorized dose
Received H1N1 vaccine on 12/8/09. 12/09/09 "I woke up at 7:00 a.m. with sore throat, cough with fire in the chest deep in the Bronchi, burning sensation when I cough, chills, fever 101.1 and continued to feel like this all day." 12/10/09 "I continued to have same symptoms achy all over and right arm in deltoid felt sore." 12/11/09 "I continued to feel sick with fever, chills, malaise, body aches. With cough. My treatment: ROBITUSSIN, TYLENOL, and indomethacin. I drank fluids and stayed home the period I was ill." On 12/17/09 "cough is gone and I only have a seasonal allergy: runny nose."
This case was reported by a healthcare professional to a sales representative and described the occurrence of flu like symptoms in an adult female subject who was vaccinated with Havrix (GlaxoSmithKline).  On 24 September 2007 the subject received 1st dose of Havrix (1440 elisa unit, unknown, unknown arm).  The subject did not receive any other vaccines on 24 September 2007.  On the morning of 25 September 2007, 1 day after vaccination with Havrix, the subject experienced flu like symptoms, nausea, headache and injection site reaction.  The subject was seen at a physician's office.  At the time of reporting the events were worse.  The vaccination course with Havrix was discontinued.  The healthcare professional considered the events were probably related to vaccination with Havrix.
Booster dose provided  to the 12 yr old no reaction noted at the time of this report
R AXILLARY adenopathy DAY 6- 10 RESOLVED Narrative: R AXILLARY adenopathy Day 6- 10 RESOLVED
pt presented following am with area of 3" long x 2.5" wide swelling. it was 2" below injection site. Warm to touch, raised and painful
She had two bad days after the second shot that she should have gone to the emergency room but she did not go; This is a spontaneous report from a contactable consumer (patient). A 63-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration on 08Feb2021 (Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 on 18Jan2021 for COVID-19 immunization and experienced hives. On an unspecified date, the patient experienced she had two bad days after the second shot that she should have gone to the emergency room but she did not go. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
got tested positive with Covid-19 today; got tested positive with Covid-19 today; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. An unspecified aged male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection) via unspecified route of administration on 15Feb2021 as single dose for covid-19 immunization. The patient's medical history and concomitant medication was not reported. Consumer (patient) got his 1st dose on 15Feb2021 and his second dose schedules on 08Mar2021. Consumer would like to know if he needs to reschedule his second dose because he got tested positive with Covid-19 today. On 01Mar2021 the patient got tested positive with Covid-19 today. The patient underwent lab tests and procedures which included covid-19: positive on 01Mar2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Dose administered to 10 patients after more than 30days of storagein the fridge; Dose administered to patient after more than 30 days of storage in the fridge prior to first use; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to 10 patients after more than 30days of storagein the fridge) and PRODUCT STORAGE ERROR (Dose administered to patient after more than 30 days of storage in the fridge prior to first use) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to 10 patients after more than 30days of storagein the fridge) and PRODUCT STORAGE ERROR (Dose administered to patient after more than 30 days of storage in the fridge prior to first use). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to 10 patients after more than 30days of storagein the fridge) and PRODUCT STORAGE ERROR (Dose administered to patient after more than 30 days of storage in the fridge prior to first use) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment medications were reported.
Right after dose I had string of pain from my right shoulder all the way down to my hand for the first 3-5 minutes. I then felt my right ear feel like it was on fire for about 3-5 minutes. About 30-60 minutes later I felt like I had a small lump in my throat. The lump didn?t bother me at first but in next several day it got bigger and bigger until I went in to urgent care 2 days later on July 26. The lump my throat did start decrease but took until Aug.  28 to finally be completely gone
Pain/swelling in right arm and chest. Chills and muscle aches. Pain and swelling in right hand. Decreased appetite.
Client was given DEPO by RN then seen by LPN to complete assessment for other vaccines. Approximately 10 minutes after DEPO, client received Hepatitis B and GARDASIL. Client was in immunization room approx 30 minutes and left clinic without incident. Mom called at 2:30 pm to state daughter had reaction after leaving clinic and was transported by ambulance to hospital. Mom stated client "turned blue & passed out". Mom stated ER gave her "nausea medication" & follow up with M.D.
Pt recv vax on 10/14/98; on 10/22/98 pt exp itchy body rash; tx=Atarax steroid injection; pt imp 2 day
Received the first dose of the Moderna COVID-19 vaccine in February; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Received the first dose of the Moderna COVID-19 vaccine in February) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Received the first dose of the Moderna COVID-19 vaccine in February). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Received the first dose of the Moderna COVID-19 vaccine in February) had resolved.            No Concomitant medication were reported.  No treatment medication were reported.  The patient now wants to get the second dose. The patient explained they lost their vaccine card and would like to know how to get a replacement?
Started with a scratchy throat; This progressed into a bad sore throat.  12/9/2023 went to Doctor, tested for Flu, Strep, and COVID-19.  Positive for Flu and COVID-19.  Rapid COVID-19.  Doctor recommended treating symptomatically.  Just experienced fatigue and sore throat, with a slight fever.  The symptoms lasted 6 or 7 days.  Then the symptoms cleared up.
This case was reported by a consumer via call center representative and described the occurrence of headache in a adult patient who received SHINGRIX for prophylaxis. On 27th September 2018, the patient received the 2nd dose of SHINGRIX. In September 2018, less than a week after receiving SHINGRIX, the patient experienced headache, chills and fever. On an unknown date, the outcome of the headache, chills and fever were unknown. It was unknown if the reporter considered the headache, chills and fever to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected adult as per vaccine indication. The day before reporting the patient received 2nd dose of the new shingles vaccine and experienced the headaches, chills and fever. The patient asked if it was ok to take aspirin or ibuprofen for the event which the patient had experienced.
A sore, red lump the size of a baseball appeared later that day on my left upper arm where I got the shots. It stopped being sore and the size went down after a few days, but I could not move my head or left arm. About a year and a half later, I fell and now I can move my head although my neck is sore and feels stiff when I move it side-to-side. I still could not move my left arm. About 6 months after that, I was sitting in a chair and my 6 year old grandson jumped on me from the right side. It caused extreme pain in my left arm, but I can now move it although it still hurts and I don't have full range of motion. It is especially difficult for me to move my left arm far enough back to hook my bra strap. I can move it to the back, but not high enough up, so I have been putting the bras on by hooking them in front and then twisting them around to have the hook in the back. I've also been placing my left arm behind me and using my right hand to push my left arm up a little each day. Now I can hook my bras in back, but it is still very difficult and very painful for my left arm. My doctors never did anything for me when I told them about it.
the pain in her arm worsened; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number unknown), via an unspecified route of administration, administered in the right arm on 21Apr2021 (at the age of 41 years old) as dose 2, single for COVID-19 immunisation. Medical history included known allergies: cillin based medicine. She was not pregnant at the time of  report. There were no concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine and other medications within two weeks of vaccination. The patient previously received first dose of BNT162B2, administered in the right arm, on 21Apr2021, at 16:30 (as reported; being clarified) (at the age of 41 years old) for COVID-19 immunisation. The patient reported that her arm was sore after shot 1. The pain subsided and then came back. After shot 2, the pain in her arm worsened on 19May2021, at 16:45. She stated it hurt to move and lift. She said she needed help and she can't afford a doctor (Dr.). The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the event. The patient has not recovered from the event at the time of report.  The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021908424 same patient, drug, and event; different dose
my left arm is swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (my left arm is swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (my left arm is swollen). At the time of the report, PERIPHERAL SWELLING (my left arm is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatments were provided.
PATIENT BECAME FAINT ANDTHEN ADMIN UNRESPONSIVE AFTER RECEIVING VACCINE . STARTED TO SWEAT . EPIPEN WAS ADMINISTERED AND PARIENT SLOWLY RETURNED TO NORMAL. PATIENT STATED THAT THEY HAVE REACTION TO INJECTIONS OR NEEDLES AND IT HAS HAPPENED BEFORE AND CONSIDERS IT PSYCOLOGICAL.
A non-serious spontaneous report of administration to 62-year-old was received from a health professional concerning a 62-year-old male. The patient's medical history was not provided. On 30-Dec-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable. The outcome of the event was considered recovered.
Breakthrough COVID case confirmed by PCR. Initial positive antigen test at home on 7/25/22.  Negative test on 7/30/22 after treatment with Paxlovid.
Spoke with client 11/24/2021 he states he has a "palm sized area under injection site that is red and warm to the touch." He states Friday night 11/19/2021 is when he discovered
This medically confirmed report concerns an 80-year-old female patient, who had a medical history of diabetes, unspecified heart condition and an allergy to penicillin and codeine. Concomitant medication included unspecified cardiac medication and unspecified medication for diabetes. On 09-Nov-2012, the patient received AFLURIA (batch no: P50408) 0.5ml. After receiving AFLURIA the patient developed a lump on her right arm at the injection site that was the size of a peach. The patient was also having a lot of difficulty lifting her right arm. She had an appointment to see her physician. The outcome was reported as not recovered. Reporter's comment: The reporter considered the event as serious due to significant disability and incapacity.